1 / 5

Global Research on Dermatophytic Onychomycosis Market to 2020: Analysis and Forecasts Report

The analysts forecast global dermatophytic onychomycosis market to grow at a CAGR of 7.44% during the period 2016-2020. The report covers the present scenario and the growth prospects of the global dermatophytic onychomycosis market for 2015-2020. To calculate the market size, the report considers revenue generated from the sales of branded, generic, and off-label drugs used to treat and prevent onychomycosis.<br>Complete Report Available at http://www.reportsnreports.com/reports/495290-global-dermatophytic-onychomycosis-market-2016-2020.html<br>

Download Presentation

Global Research on Dermatophytic Onychomycosis Market to 2020: Analysis and Forecasts Report

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Global Dermatophytic Onychomycosis Market 2016-2020 - Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on sales@reportsandreports.com with Dermatophytic Onychomycosis Market in subject line and your contact details. Read 57 Pages Report at http://www.reportsnreports.com/reports/495290-global- dermatophytic-onychomycosis-market-2016-2020.html . Dermatophytic onychomycosis is a fungal infection of the nail plate, nail bed, and, in some cases, the skin surrounding the nail plate. It is caused by yeast, dermatophytes, and molds; dermatophytes account for 90% of all cases. The fungus, especially Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, infects the skin, hair, or nails. It is often perceived by people to be an active and contagious infection. Onychomycosis may persist or worsen if not treated. The fungi that cause onychomycosis exist in common sites such as floors, soil, socks, and shoes. Therapies for onychomycosis include debridement and drugs. Debridement is time consuming and minimally effective in eradicating the fungal infection. Systemic drug treatment is most effective in treating onychomycosis. The analysts forecast global dermatophytic onychomycosis market to grow at a CAGR of 7.44% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global dermatophytic onychomycosis market for 2015-2020. To calculate the market size, the report considers revenue generated from the sales of branded, generic, and off-label drugs used to treat and prevent onychomycosis. The market is divided into the following segments based on geography: APAC EMEA Americas The report, Global Dermatophytic Onychomycosis Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market. Buy a copy of report @http://www.reportsnreports.com/Purchase.aspx?name=495290 for US $2500. Global Dermatophytic Onychomycosis Market 2016-2020

  2. Key vendors Anacor Pharmaceuticals Galderma Janssen Biotech Novartis Valeant Pharmaceuticals Other prominent vendors Abeona Therapeutics Allergan Elorac GlaxoSmithKline Hexima Hisamitsu Pharmaceutical Mayne Pharma MediQuest Therapeutics Meiji Seika Pharma Merz Pharma Moberg Pharma NanoBio NovaBiotics Nuvo Research Pfizer Polichem Promius Pharma Sanofi Seren Pharmaceuticals Taro Pharmaceutical Topica Pharmaceuticals Viamet Pharmaceuticals Inquire before Buying at http://www.reportsnreports.com/contacts/Discount.aspx?name=495290 . Market driver Increase in R&D Global Dermatophytic Onychomycosis Market 2016-2020

  3. Market challenge Adverse effects and limited efficacy of drugs Market trend Increased focus on combination therapies Key questions answered in this report 1.What will the market size be in 2020 and what will the growth rate be? 2.What are the key market trends? 3.What is driving this market? 4.What are the challenges to market growth? 5.Who are the Key vendors in this market space? 6.What are the market opportunities and threats faced by the key vendors? 7.What are the strengths and weaknesses of the key vendors? Inquire for Discount at http://www.reportsnreports.com/contacts/Discount.aspx?name=495290 . List of Exhibits Exhibit 01: Key buying criteria for dermatophytic onychomycosis drugs Exhibit 02: Percentage of population undergoing treatment globally 2015 Exhibit 03: Pharmacological treatment for dermatophytic onychomycosis Exhibit 04: Treatment algorithm for dermatophytic onychomycosis Exhibit 05: Global dermatophytic onychomycosis therapeutics market overview Exhibit 06: Global dermatophytic onychomycosis market 2015-2020 ($ billions) Exhibit 07: Five forces analysis Exhibit 08: Comparison of activity of topical medications for onychomycosis Exhibit 09: Comparison of activity of oral medications for onychomycosis Global Dermatophytic Onychomycosis Market 2016-2020

  4. Exhibit 10: Global dermatophytic onychomycosis market segmentation by route of administration based on volume 2015 Exhibit 11: Dermatophytic onychomycosis market in US by route of administration based on revenue 2015 Exhibit 12: Segmentation of global dermatophytic onychomycosis market based on geography 2015 Exhibit 13: Global dermatophytic onychomycosis market revenue by geography 2015-2020 ($ billions) Exhibit 14: Dermatophytic onychomycosis market in Americas 2015-2020 ($ billions) Exhibit 15: Dermatophytic onychomycosis market in EMEA 2015-2020 ($ billions) Exhibit 16: Dermatophytic onychomycosis market in APAC 2015-2020 ($ billions) Exhibit 17: Global dermatophytic onychomycosis market: YoY growth and revenue based on geography 2015-2020 Exhibit 18: Comparison of onychomycosis prevalence with major diseases in US 2013 Exhibit 19: Impact of drivers Exhibit 20: Impact of drivers and challenges Exhibit 21: Anacor Pharmaceuticals: Key takeaways Exhibit 22: Galderma: Key takeaways Exhibit 23: Janssen Biotech: Key takeaways Exhibit 24: Novartis: Key takeaways Exhibit 25: Valeant Pharmaceuticals: Key takeaways Browse All Reports on Pharmaceuticals About Us: Global Dermatophytic Onychomycosis Market 2016-2020

  5. ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. Global Dermatophytic Onychomycosis Market 2016-2020

More Related